Navigation Links
Accumetrics Appoints John J. Young, MD Chief Medical Officer
Date:11/11/2008

SAN DIEGO, Nov. 11 /PRNewswire/ -- Accumetrics, Inc. has announced the appointment of John J. Young, MD as Chief Medical Officer for the company. Dr. Young will serve in a part-time capacity in addition to his current appointment as Professor of Medicine and Director of the Cardiovascular Innovations Program at The Ohio State University in Columbus, Ohio. Dr. Young will serve as the main liaison to practicing clinicians, as well as coordinating ongoing research efforts and educational strategies.

"We are very pleased to welcome John to Accumetrics," said Timothy Still, President and CEO of The Company. "We look forward to leveraging his unique experience as a clinical investigator, as well as clinical expertise to continue to grow our Company."

Prior to joining The Ohio State University Medical Center, Dr. Young was the Co-Director of Cardiovascular Research & Education at the Swedish Heart & Vascular Institute in Seattle, Washington. Prior positions included Associate Director of the Lindner Center for Research & Education, and Director of Interventional Services at the Ohio Heart & Vascular Center, both in Cincinnati, Ohio. Dr. Young received his M.D. from The Ohio State University College of Medicine, where he completed both his Residency and Fellowship training. He also holds a Bachelor of Science degree in chemistry, with honors, from Wright State University, Dayton, OH. Finally, Dr. Young has received the distinction of being one of the "Best Doctors in America," and is a lifetime member of "Who's Who in Medicine & Healthcare."

About Accumetrics (http://www.accumetrics.com)

Accumetrics is committed to advancing medical understanding of platelet function and enhancing quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.

Accumetrics' VerifyNow(R) System is the first rapid and easy to use platform for measuring an individual's response to multiple antiplatelet agents. Addressing every major antiplatelet drug, including FDA-cleared products for aspirin, Plavix(R), ReoPro(R), and Integrilin(R), the VerifyNow System provides a valuable tool to help physicians make informed treatment decisions.

The Accumetrics logo and VerifyNow are registered trademarks of Accumetrics, Inc., ReoPro is a registered trademark of Centocor, Inc. Integrilin is a registered trademark of Millennium Pharmaceuticals. Plavix is a registered trademark of Sanofi-Aventis.

CONTACT:

Jules Abraham

Lippert/Heilshorn & Associates

212-838-3777

jabraham@lhai.com


'/>"/>
SOURCE Accumetrics
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Timothy I. Still Appointed CEO at Accumetrics
2. Potentia Pharmaceuticals Appoints Johanna M. Seddon, M.D. and Janet Stoltz Sunness, M.D. to Scientific Advisory Board
3. Cynvec LLC(SM) Appoints Former Johnson & Johnson Executive Frank D. Stonebanks as President and Chief Executive Officer
4. Kendle Reappoints Former CFO Timothy M. Mooney to Board of Directors
5. NutraCea Appoints New Chief Financial Officer
6. Cardiac Science Appoints Dave Marver as Chief Operating Officer
7. Nutrition 21 Appoints Pam McWilliams, Vice President - General Manager of Direct Response
8. Senesco Appoints Harlan W. Waksal, M.D., to Board of Directors
9. Boston Healthcare Appoints Adam Barak as Vice President Enhancing Its International Pricing and Reimbursement Capability
10. Nikon Instruments Appoints LABSCO its Clinical Distributor in Six States
11. China Pharma Holdings, Inc. Appoints The Ruth Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... , ... Supplyframe, the Industry Network for electronics hardware design ... Located in Pasadena, Calif., the Design Lab’s mission is to bring together inventors ... and brought to market. , The Design Lab is Supplyframe’s physical representation of ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... -- On Wednesday, June 22, 2016, the NASDAQ ... Dow Jones Industrial Average edged 0.27% lower to finish at ... Stock-Callers.com has initiated coverage on the following equities: Infinity Pharmaceuticals ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ... Learn more about these stocks by accessing their free trade ...
(Date:6/23/2016)... ... 2016 , ... Velocity Products, a division of Morris Group, ... exclusively for Okuma CNC machining centers at The International Manufacturing Technology Show, IMTS, ... companies with expertise in toolholding, cutting tools, machining dynamics and distribution, Velocity SMART ...
Breaking Biology Technology:
(Date:6/2/2016)... 2016   The Weather Company , an IBM Business ... industry-first capability in which consumers will be able to interact ... questions via voice or text and receive relevant information about ... Marketers have long sought an advertising solution that can ... personal, relevant and valuable; and can scale across millions of ...
(Date:5/20/2016)... MINNEAPOLIS , May 20, 2016  VoiceIt ... technology partnership with VoicePass. By working ... user experience.  Because VoiceIt and VoicePass take slightly ... two engines increases both security and usability. ... expressed excitement about this new partnership. ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
Breaking Biology News(10 mins):